Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 5:18 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 841–864 of 2,551 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Neurodevelopmental Disorder Clear all

Conditions: Attention Deficit Disorder With Hyperactivity
Interventions: Methylphenidate Transdermal System; Drug
Lead sponsor: Noven Therapeutics; Industry
Eligibility: 6 Years to 12 Years
Enrollment: 93 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2005
U.S. locations: 1
States / cities: Irvine, California

Conditions: Klinefelter Syndrome, Trisomy X, XYY Syndrome, XXXY and XXXXY Syndrome, Xxyy Syndrome, Xyyy Syndrome, Xxxx Syndrome, Xxxxx Syndrome, Xxxyy Syndrome, Xxyyy Syndrome, Xyyyy Syndrome, Male With Sex Chromosome Mosaicism
Interventions: Assessments of Development and Growth; Other
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 6 Weeks to 13 Months
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2028
U.S. locations: 2
States / cities: Aurora, Colorado • Philadelphia, Pennsylvania

Conditions: Epilepsy, Seizure Disorder, Neurologic Disorder, Rare Diseases
Interventions: Clinical care and quality improvement; Other
Lead sponsor: Epilepsy Foundation of America; Other
Eligibility: Not listed
Enrollment: 100,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2099
U.S. locations: 13
States / cities: Phoenix, Arizona • Los Angeles, California • Aurora, Colorado + 7 more

Conditions: Attention Deficit Hyperactivity Disorder, Attention Deficit Disorders With Hyperactivity, Attention Deficit Hyperactivity Disorders
Interventions: NRP104; Drug
Lead sponsor: New River Pharmaceuticals; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 420 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006
U.S. locations: 48
States / cities: Little Rock, Arkansas • El Centro, California • Irvine, California + 43 more

Conditions: Autism Spectrum Disorder, Depression, Anxiety
Interventions: Cognitive-Behavioral Therapy (CBT), Mindfulness-Based Cognitive Therapy (MBCT); Behavioral
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 2
States / cities: Chapel Hill, North Carolina • Charlottesville, Virginia

Conditions: Infant, Newborn, Infant, Low Birth Weight, Infant, Small for Gestational Age, Infant, Premature, Cerebral Palsy
Interventions: Not listed
Lead sponsor: NICHD Neonatal Research Network; Network
Eligibility: Up to 72 Hours
Enrollment: 1,067 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1999 – 2004
U.S. locations: 18
States / cities: Birmingham, Alabama • Palo Alto, California • San Diego, California + 14 more

Conditions: Stress
Interventions: Cognitive Based Compassion Training Session: Developing Attention and Stability of Mind, Cognitive Based Compassion Training Session: Cultivating Insight into the Nature of Mental Experience, Cognitive Based Compassion Training Session: Self-compassion, Cognitive Based Compassion Training Session: Cultivating Equanimity, Cognitive Based Compassion Training Session: Developing Appreciation and Gratitude for Others, Cognitive Based Compassion Training Session: Developing Affection and Empathy, Cognitive Based Compassion Training Session: Realizing Wishing and Aspiring Compassion, Cognitive Based Compassion Training Session: Realizing Active Compassion, Meditation Session; Behavioral
Lead sponsor: Emory University; Other
Eligibility: Not listed
Enrollment: 29 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2016
U.S. locations: 2
States / cities: Atlanta, Georgia

Conditions: Congenital Disorders of Glycosylation
Interventions: Not listed
Lead sponsor: National Human Genome Research Institute (NHGRI); NIH
Eligibility: 1 Month to 80 Years
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2030
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Attention-Deficit/Hyperactivity Disorder (ADHD)
Interventions: Not listed
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 13 Years to 18 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Cambridge, Massachusetts

Conditions: Autism Spectrum Disorder, Anesthesia, Procedural Anxiety, Sensory Processing Disorder
Interventions: Sensory adaptive environment; Other
Lead sponsor: Dayton Children's Hospital; Other
Eligibility: 3 Years to 12 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Dayton, Ohio

Conditions: Asperger Syndrome, High Functioning Autism
Interventions: PVGS; Behavioral
Lead sponsor: Minna Levine, PhD; Industry
Eligibility: 11 Years to 21 Years
Enrollment: 47 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Belmont, Massachusetts

Conditions: Borderline Personality Disorder, BPD, Schizotypal Personality Disorder, SPD, Autism Spectrum Disorder, Schizophrenia, Schizoaffective Disorder, Bipolar Disorder
Interventions: Syntocinon 24 Intranasal Units (IU), Syntocinon 40 Intranasal Units (IU), Intranasal Placebo; Drug
Lead sponsor: Maria de las Mercedes Perez Rodriguez; Other
Eligibility: 18 Years to 65 Years
Enrollment: 92 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2022
U.S. locations: 2
States / cities: New York, New York • The Bronx, New York

Conditions: Autism Spectrum Disorder, Anxiety Disorders, Emotion Regulation
Interventions: Zones of Regulation, Facing Your Fears - School Based; Behavioral
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 7 Years to 15 Years
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Separation Anxiety Disorder, Generalized Anxiety Disorder, Social Phobia
Interventions: Acoustic Neuromodulation (ANM); Other
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 7 Years to 17 Years
Enrollment: 6 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: New York, New York

Conditions: Development; Delayed, Mental, Anxiety, Situational Anxiety, Fear of Other Medical Care, Behavior, Coping, Behavior Disorders, Psychological Disorder, Behavior Disorders in Children
Interventions: Not listed
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 3 Years to 21 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Speech Sound Disorder, Phonology Disorder, Phonology Impairment, Phonological Disorder, Articulation Disorders in Children, Developmental Phonological Disorder, Speech Disorders, Speech Delay, Articulation Disorders, Developmental
Interventions: articulation therapy, phonologic treatment; Behavioral
Lead sponsor: University of Wyoming; Other
Eligibility: 4 Years to 8 Years
Enrollment: 16 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Laramie, Wyoming

Conditions: Bipolar Disorder, ADHD
Interventions: Proton Magnetic Resonance Spectroscopy; Device
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 6 Years to 17 Years
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2002 – 2005
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Attention-deficit/Hyperactivity Disorder
Interventions: Lisdexamfetamine dimesylate, Methylphenidate Hydrochloride, Placebo; Drug
Lead sponsor: Shire; Industry
Eligibility: 13 Years to 17 Years
Enrollment: 549 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 81
States / cities: Dothan, Alabama • Tucson, Arizona • Little Rock, Arkansas + 68 more

Conditions: Autism Spectrum Disorder
Interventions: Gamified mobile health app; Behavioral
Lead sponsor: University of Delaware; Other
Eligibility: 18 Years to 55 Years
Enrollment: 70 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Newark, Delaware

Conditions: Autistic Disorder, Enuresis
Interventions: Moisture Pager Intervention for Toilet Training, Standard of Care; Behavioral
Lead sponsor: University of Rochester; Other
Eligibility: 3 Years to 10 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2018
U.S. locations: 3
States / cities: Rochester, New York • Columbus, Ohio • Nashville, Tennessee

Conditions: Autism Spectrum Disorder, Autism
Interventions: Pivotal Response Treatment Online (PRT-O) Course; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 2 Years to 5 Years
Enrollment: 44 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Stanford, California

Conditions: Autism
Interventions: docosahexaenoic acid (DHA), Placebo; Dietary Supplement
Lead sponsor: Mayo Clinic; Other
Eligibility: 3 Years to 10 Years
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2007
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Attention-Deficit/Hyperactivity Disorder
Interventions: SPN-812; Drug
Lead sponsor: Supernus Pharmaceuticals, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 161 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: New York, New York

Conditions: Attention Deficit Hyperactivity Disorder
Interventions: Experimental: methylphenidate treatment; Drug
Lead sponsor: University of California, Irvine; Other
Eligibility: 18 Years to 45 Years
Enrollment: 75 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: Irvine, California

Search by objective public record fields.

Classroom Study to Assess Efficacy and Safety of MTS in Pediatric Patients Aged 6-12 With ADHD

The eXtroardinarY Babies Study: Natural History of Health and Neurodevelopment in Infants and Young Children With Sex Chromosome Trisomy

Epilepsy Learning Healthcare System (ELHS)

Study to Assess the Safety and Efficacy of NRP104 in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)

Comparing Cognitive-Behavioral Therapy Versus Mindfulness-Based Therapy for Autistic Adults

Inflammatory Cytokines Associated With Perinatal Brain Injury

CBCT for Parents of Children With Autism

Clinical and Basic Investigations Into Known and Suspected Congenital Disorders of Glycosylation

Comparison of Self and Clinician Administered Rating Scales in Patients With ADHD

Use of an Adaptive Sensory Environment in Autism Spectrum Disorder (ASD) Patients in the Perioperative Environment

Portable Visual Guidance System Phase II

Examining Dose-Related Effects of Oxytocin on Social Cognition Across Populations

A Comparison of Two School Based Interventions to Manage Anxiety in Autistic Students

Acoustic Neuromodulation (ANM) for Youth With Anxiety Disorders

Adaptive Care in the Perioperative Setting

Age-related Correlates of Treatment for Late-acquired Sounds

Spectroscopy in Children and Adolescents With Bipolar Disorder

Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder

Development and Evaluation of A Game-Based Mobile App for Increasing Physical Activity in Autistic Adults

Investigation of Teacher-Mediated Toilet Training Using a Manualized Moisture Alarm Intervention

Online Pivotal Response Treatment Training in Autism Spectrum Disorder

Docosahexaenoic Acid in the Treatment of Autism

Open-label Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD and Mood Symptoms

Brain Dopamine Function in Adults With ADHD